Hitachi High-Technologies Develops Enhanced Microwave ECR Etching Module

Achieves Damage-Free Atomic-Level Etching with a Wide Range of Optional Functions Conductor Etch System 9000-Series (Photo: Business Wire) March 22, 2018 01:00 AM Pacific Daylight Time TOKYO–(BUSINESS WIRE)–Hitachi High-Technologies Corporation (TSE: 8036) (Hitachi High-Tech) announced the development of the Enhanced Microwave ECR*1 Etching Module (the “Module”), a new product designed for next-generation semiconductor device manufacturing processes.... Read more

Bio-Techne Expands RNAscope® ISH Automation – Facilitating Drug Discovery and Development

New and updated assays increase application areas and improve performance MINNEAPOLIS, March 21, 2018 /PRNewswire/ — Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays. The developments increase both access to, and use of, RNAscope and improve overall robustness and ease-of-use.... Read more

Neogen’s Listeria Right Now™ wins CFIA innovation award

CONTACT: Joanne McPeake, Neogen Europe Ltd., +44(0) 1292 525 600 AYR, Scotland, 21 March, 2018 — Neogen’s revolutionary Listeria Right Now™ environmental pathogen detection system has won a 2018 CFIA innovation trophy. The CFIA (Carrefour des Fournisseurs de l’Industrie Agroalimentaire) is an annual agro-food industry supplier fair held in France that showcases the latest developments in food industry technology.... Read more

“Hitachi High-Tech Science Park Shanghai Lab” to Open in Shanghai, China

— Establishing a global laboratory structure covering nine locations in five countries — Shanghai, China, March 20, 2018—Hitachi High-Technologies (Shanghai) Co., Ltd., a Chinese subsidiary of Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announces that it has opened “Hitachi High-Tech Science Park Shanghai Lab” (Shanghai Lab) in Shanghai, China on June 20, 2018 to promote... Read more

Oxford Nanopore announces £100 million ($140M) fundraising from global investors

Tue 20th March 2018 Funding will support new manufacturing facility, commercial expansion, and development of new innovative products. Oxford, UK. Oxford Nanopore Technologies Ltd, the company behind the only portable real-time DNA/RNA sequencer, MinION, has raised £100M ($140M) in new investment. Funds were raised from global investors including GIC (Singapore), CCB International (CCBI, China), Hostplus (Australia),... Read more

ATL Announces Appointment of Steve Chase as Chief Executive Officer

March 20, 2018: Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Systems (LIMS), is pleased to announce that Steve Chase is joining the company as Chief Executive Officer (CEO). This appointment is effective immediately and concludes a search process conducted by ATL’s executive leadership team. As CEO, Steve will oversee ATL’s ambitious near... Read more

BIRAC and PerkinElmer Sign Letter of Intent to Promote India-Led Startups and Innovations

NEW DELHI–(BUSINESS WIRE)–The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 6th Foundation Day on Tuesday in New Delhi. The event, aptly themed ‘Sustaining Innovation: A Market Driven Pathway’, was presided over by the Hon’ble Minister of State for Science and Technology & Earth Sciences, Dr Harsh Vardhan, Prof. Ashutosh Sharma, Secretary, Department of Biotechnology... Read more

Advion Launches Open Port Sampling Interface – Novel Sample Introduction enhances the analysis of proteins, peptides and antibodies

ITHACA, N.Y., March 20, 2018  /PRNewswire/ — Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces the release of the Open Port Sampling Interface, or OPSI, designed for simple sampling of solids, liquids, and sample preparation tips and fibers. The novel ambient sampling technique was invented by Gary van Berkel and Vilmos Ketesz of Oak... Read more

Quanterix Corporation and DestiNA Genomics to Collaborate in Effort to Transform microRNA Biomarker Detection

Collaboration offers potential for PCR-free microRNA biomarker detection with high-specificity and ultra-sensitivity March 20, 2018 06:00 AM Pacific Daylight Time LEXINGTON, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration with DestiNA Genomics, a manufacturer of patented reagents for nucleic acid detection.... Read more

Gyros Protein Technologies introduces Gyrolab xPand to improve immunoassay workflow, flexibility and speed in biotherapeutic discovery, development and production

New 5 CD platform combines Gyrolab® immunoassay technology with expanded software to optimize time to results and sample capacity while simplifying workflows Gyrolab xPand will be showcased on March 19-22 at BPI West in San Francisco and April 9-13 at WRIB in Philadelphia Uppsala, Sweden, 19 March 2018: Gyros Protein Technologies AB, a pioneer in automated... Read more